These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1149 related items for PubMed ID: 12737449

  • 1. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K, Brandsaeter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E.
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [Abstract] [Full Text] [Related]

  • 2. Secondary Osteoporosis in Liver Transplant Recipients: a Longitudinal Study in Patients With and Without Cholestatic Liver Disease.
    Bjøro K, Brandsæter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E.
    Scand J Gastroenterol; 2003 Mar; 38(3):320-327. PubMed ID: 28248598
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation.
    Ebeling PR, Thomas DM, Erbas B, Hopper JL, Szer J, Grigg AP.
    J Bone Miner Res; 1999 Mar; 14(3):342-50. PubMed ID: 10027899
    [Abstract] [Full Text] [Related]

  • 4. Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
    Burshell AL, Möricke R, Correa-Rotter R, Chen P, Warner MR, Dalsky GP, Taylor KA, Krege JH.
    Bone; 2010 Apr; 46(4):935-9. PubMed ID: 20060081
    [Abstract] [Full Text] [Related]

  • 5. Is bone turnover a determinant of bone mass in rheumatoid arthritis?
    Cortet B, Flipo RM, Pigny P, Duquesnoy B, Boersma A, Marchandise X, Delcambre B.
    J Rheumatol; 1998 Dec; 25(12):2339-44. PubMed ID: 9858427
    [Abstract] [Full Text] [Related]

  • 6. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation.
    Dodidou P, Bruckner T, Hosch S, Haass M, Klar E, Sauer P, Ziegler R, Leidig-Bruckner G.
    Osteoporos Int; 2003 Jan; 14(1):82-9. PubMed ID: 12577189
    [Abstract] [Full Text] [Related]

  • 7. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y, Jamart J, Esselinckx W, Devogelaer JP.
    J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
    [Abstract] [Full Text] [Related]

  • 8. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF, Margioris AN, Dretakis KE, Trovas G, Zoras U, Lyritis G, Dretakis EK, Stergiopoulos K.
    Maturitas; 2004 Mar 15; 47(3):185-93. PubMed ID: 15036488
    [Abstract] [Full Text] [Related]

  • 9. Relationship between bone turnover and bone density at the proximal femur in stroke patients.
    Paker N, Bugdayci D, Tekdos D, Dere C, Kaya B.
    J Stroke Cerebrovasc Dis; 2009 Mar 15; 18(2):139-43. PubMed ID: 19251190
    [Abstract] [Full Text] [Related]

  • 10. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
    Fahrleitner A, Prenner G, Kniepeiss D, Iberer F, Tscheliessnigg KH, Piswanger-Sölkner C, Obermayer-Pietsch B, Leb G, Dobnig H.
    Wien Klin Wochenschr; 2002 Aug 30; 114(15-16):717-24. PubMed ID: 12602117
    [Abstract] [Full Text] [Related]

  • 11. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D.
    Am J Gastroenterol; 1998 Sep 30; 93(9):1483-90. PubMed ID: 9732930
    [Abstract] [Full Text] [Related]

  • 12. Elevation of intact parathyroid hormone level is a risk factor for low bone mineral density in pretransplant patients with liver diseases.
    Bai XL, Liang TB, Wu LH, Li DL, Geng L, Wang WL, Shen Y, Zhang M, Zheng SS.
    Transplant Proc; 2007 Dec 30; 39(10):3182-5. PubMed ID: 18089348
    [Abstract] [Full Text] [Related]

  • 13. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease.
    Dresner-Pollak R, Karmeli F, Eliakim R, Ackerman Z, Rachmilewitz D.
    Am J Gastroenterol; 2000 Mar 30; 95(3):699-704. PubMed ID: 10710060
    [Abstract] [Full Text] [Related]

  • 14. Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study.
    Marcén R, Caballero C, Pascual J, Teruel JL, Tenorio M, Ocaña J, Villafruela JJ, Burgos FJ, Fernández AM, Muriel A, Ortuño J.
    Transplantation; 2006 Mar 27; 81(6):826-31. PubMed ID: 16570003
    [Abstract] [Full Text] [Related]

  • 15. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.
    Goffin E, Devogelaer JP, Lalaoui A, Depresseux G, De Naeyer P, Squifflet JP, Pirson Y, van Ypersele de Strihou C.
    Transpl Int; 2002 Mar 27; 15(2-3):73-80. PubMed ID: 11935163
    [Abstract] [Full Text] [Related]

  • 16. Evolution of bone disease at 2 years after transplantation: a single-center study.
    Falkiewicz K, Boratyńska M, Zmonarski SC, Milewicz A, Patrzałek D, Biecek P, Klinger M.
    Transplant Proc; 2009 Oct 27; 41(8):3063-6. PubMed ID: 19857677
    [Abstract] [Full Text] [Related]

  • 17. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF, Geyikli I, Yazgan P, Celik A.
    Arch Gynecol Obstet; 2006 Jun 27; 274(3):133-7. PubMed ID: 16532321
    [Abstract] [Full Text] [Related]

  • 18. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.
    Perez EA, Josse RG, Pritchard KI, Ingle JN, Martino S, Findlay BP, Shenkier TN, Tozer RG, Palmer MJ, Shepherd LE, Liu S, Tu D, Goss PE.
    J Clin Oncol; 2006 Aug 01; 24(22):3629-35. PubMed ID: 16822845
    [Abstract] [Full Text] [Related]

  • 19. [The use of parenteral clodronate in elderly women with postmenopausal osteoporosis: compliance, effects on bone mineral density and on bone turnover].
    Celi M, Balducci S, Schiappoli A, Caliumi C, Petramala L, Cerci S, Cotesta D, D'Erasmo E, Letizia C.
    Ann Ital Med Int; 2003 Aug 01; 18(2):89-98. PubMed ID: 12886826
    [Abstract] [Full Text] [Related]

  • 20. Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients.
    Bozkaya G, Nart A, Uslu A, Onman T, Aykas A, Doğan M, Karaca B.
    Transplant Proc; 2008 Aug 01; 40(1):151-5. PubMed ID: 18261573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.